Aditxt Inc ADTX:NASDAQ

RT Quote | USD
Last | 05/02/24 EDT
2.47quote price arrow up+0.06 (+2.49%)
Volume
15,470
52 week range
2.14 - 68.08
Loading...
  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close2.41
  • 52 Week High68.08
  • 52 Week High Date08/31/23
  • 52 Week Low2.14
  • 52 Week Low Date04/22/24

Key Stats

  • Market Cap4.113M
  • Shares Out1.67M
  • 10 Day Average Volume0.05M
  • Dividend-
  • Dividend Yield-
  • Beta1.08
  • YTD % Change-62.75

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close2.41
  • 52 Week High68.08
  • 52 Week High Date08/31/23
  • 52 Week Low2.14
  • 52 Week Low Date04/22/24
  • Market Cap4.113M
  • Shares Out1.67M
  • 10 Day Average Volume0.05M
  • Dividend-
  • Dividend Yield-
  • Beta1.08
  • YTD % Change-62.75

RATIOS/PROFITABILITY

  • EPS (TTM)-153.12
  • P/E (TTM)-0.02
  • Fwd P/E (NTM)-0.06
  • EBITDA (TTM)-25.52M
  • ROE (TTM)-307.59%
  • Revenue (TTM)645,190.001
  • Gross Margin (TTM)-17.30%
  • Net Margin (TTM)-5,020.30%
  • Debt To Equity (MRQ)100.75%

EVENTS

  • Earnings Date05/16/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Aditxt Inc

 

Profile

MORE
Aditxt, Inc. is a biotech company focused on discovering, developing, and deploying health innovations. It develops and commercializes technologies with a focus on monitoring and modulating the immune system. Its portfolio includes Adimune, Inc., developing a new class of therapeutics designed to retrain the immune system to address organ rejection, autoimmunity, and allergies; Adivir, Inc., focused on identifying, developing, and commercializing new ways to treat infectious...
Amro Albanna
Chairman of the Board, Chief Executive Officer
Rowena Albanna
Chief Operating Officer
Thomas Farley
Chief Financial Officer
Address
737 N. Fifth Street, Suite 200
Richmond, VA
23219
United States